AI-generated summary
This brief narrative review describes photobiomodulation, a form of low-dose light therapy, and its use in supportive cancer care. The authors report that recent systematic reviews and meta-analyses recommend its routine use for acute and chronic side effects of cancer treatment, particularly oral mucositis. They also discuss molecular mechanisms and the need for harmonized dosing.
- Who or what was studied
- Patients receiving cancer treatment, including radiotherapy for head and neck cancer, chemotherapy, or hematopoietic stem cell transplantation
- Limits stated in the abstract
- The abstract describes a narrative review and does not report the number of studies, participants, or specific wavelengths or doses used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Oral mucositis, Dosimetry, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.